A collagen-targeted biomimetic RGD peptide to promote osteogenesis

Tissue Engineering - Part A

Volumn 20, Issue 1-2, 2014, Pages 34-44

  Visser, Rick ^a,b,c   Arrabal, Pilar M ^a,b,c   Santos Ruiz, Leonor ^a,b,c   Fernandez Barranco, Raul ^a,c   Becerra, Jose ^a,b,c   Cifuentes, Manuel ^a,b,c  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOMIMETICS; IODINE; MOLECULAR BIOLOGY; PEPTIDES; STEM CELLS;

ARGININE-GLYCINE-ASPARTIC ACIDS; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; BONE MORPHOGENETIC PROTEINS; CHEMICAL MANIPULATION; COLLAGEN BINDING DOMAIN; MULTIFACTORIAL PROCESS; OSTEOBLASTIC DIFFERENTIATION; VON WILLEBRAND FACTOR;

COLLAGEN;

ABSORBABLE COLLAGEN TYPE I SPONGE; ARGINYLGLYCYLASPARTIC ACID; BIOMIMETIC MATERIAL; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN SPONGE; COLLAGEN TARGETED ARGINYLGLYCYLASPARTIC ACID BIOMIMETIC PEPTIDE; COLLAGEN TYPE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ALKALINE PHOSPHATASE; ANIMALS; BIOMIMETIC MATERIALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CASPASES; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; OLIGOPEPTIDES; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, INBRED F344; VINCULIN;

EID: 84891527405     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0610     Document Type: Article

References (39)

1. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., LaForte, A.J., and Yin, S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
2. Boden, S.D., Kang, J., Sandhu, H., and Heller, J.G. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27, 2662, 2002.
3. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Bö rner, M.G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Feibel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., van der Velde, D., Hardy, P., Holt, M., Josten, C., Ketterl, R.L., Lindeque, B., Lob, G., Mathevon, H., McCoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P.M., Rondia, J., Rossouw, W.C., Daneel, P.J., Ruff, S., Rüter, A., Santavirta, S., Schildhauer, T.A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R.B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A., Wisniewski, T., and BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A, 2123, 2002.
4. Vaccaro, A.R., Patel, T., Fischgrund, J., Anderson, D.G., Truumees, E., Herkowitz, H.N., Phillips, F., Hilibrand, A., Albert, T.J., Wetzel, T., and McCulloch, J.A. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 29, 1885, 2004.
5. Swiontkowski, M.F., Aro, H.T., Donell, S., Esterhai, J.L., Goulet, J., Jones, A., Kregor, P.J., Nordsletten, L., Paiement, G., and Patel, A. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88, 1258, 2006.
6. Garrison, K.R., Donell, S., Ryder, J., Shemilt, I., Mugford, M., Harvey, I., and Song, F. Clinical effectiveness and costeffectiveness of bone morphogenetic proteins in the nonhealing of fractures and spinal fusion: a systematic review. Health Technol Assess 11, 1, 2007.
7. Granjeiro, J.M., Oliveira, R.C., Bustos-Valenzuela, J.C., Sogayar, M.C., and Taga, R. Bone morphogenetic proteins: from structure to clinical use. Braz J Med Biol Res 38, 1463, 2005.
8. Seeherman, H.J., Bouxsein, M., Kim, H., Li, R., Li, X.J., Aiolova, M., and Wozney, J.M. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J Bone Joint Surg Am 86-A, 1961, 2004.
9. Hulsart-Billström, G., Hu, Q., Bergman, K., Jonsson, K.B., Berg, J., Tang, R., Larsson, S., and Hilborn, J. Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats. Acta Biomater 7, 3042, 2011.
10. Visser, R., Arrabal, P.M., Becerra, J., Rinas, U., and Cifuentes, M. The effect of an rhBMP-2 absorbable collagen spongetargeted system on bone formation in vivo. Biomaterials 30, 2032, 2009.
11. Akita, S., Fukui, M., Nakagawa, H., Fujii, T., and Akino, K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen 12, 252, 2004.
12. Kakudo, N., Kusumoto, K., Kuro, A., and Ogawa, Y. Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats. Wound Repair Regen 14, 336, 2006
13. Kempen, D.H., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., Yaszemski, M.J., and Dhert, W.J. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
14. Huang, Z., Ren, P.G., Ma, T., Smith, R.L., and Goodman, S.B. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 51, 305, 2010.
15. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., LaPan, P., Luxenberg, D.P., McQuaid, D., Moutsatsos, I.K., Nove, J., and Wozney, J.M. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87, 2220, 1990.
16. Volek-Smith, H., and Urist, M.R. Recombinant human bone morphogenetic protein (rhBMP) induced heterotopic bone development in vivo and in vitro. Proc Soc Exp Biol Med 211, 265, 1996.
17. García, A.J., and Reyes, C.D. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. J Dent Res 84, 407, 2005.
18. Le Guillou-Buffello, D., Bareille, R., Gindre, M., Sewing, A., Laugier, P., and Amédée, J. Additive effect of RGD coating to functionalized titanium surfaces on human osteoprogenitor cell adhesion and spreading. Tissue Eng Part A 14, 1445, 2008.
19. Germanier, Y., Tosatti, S., Broggini, N., Textor, M., and Buser, D. Enhanced bone apposition around biofunctionalized sandblasted and acid-etched titanium implant surfaces. A histomorphometric study in miniature pigs. Clin Oral Implants Res 17, 251, 2006.
20. Petrie, T.A., Raynor, J.E., Reyes, C.D., Burns, K.L., Collard, D.M., and García, A.J. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration. Biomaterials 29, 2849, 2008.
21. Moore, N.M., Lin, N.J., Gallant, N.D., and Becker, M.L. Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2- derived and RGD peptide concentration gradients. Acta Biomater 7, 2091, 2011.
22. Park, J.S., Yang, H.N., Jeon, S.Y., Woo, D.G., Na, K., and Park, K.H. Osteogenic differentiation of human mesenchymal stem cells using RGD-modified BMP-2 coated microspheres. Biomaterials 31, 6239, 2010.
23. Song, D.P., Chen, M.J., Liang, Y.C., Bai, Q.S., Chen, J.X., and Zheng, X.F. Adsorption of tripeptide RGD on rutile TiO(2) nanotopography surface in aqueous solution. Acta Biomater 6, 684, 2010.
24. Ferris, D.M., Moodie, G.D., Dimond, P.M., Gioranni, C.W., Ehrlich, M.G., and Valentini, R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 20, 2323, 1999.
25. Oya, K., Tanaka, Y., Saito, H., Kurashima, K., Nogi, K., Tsutsumi, H., Tsutsumi, Y., Doi, H., Nomura, N., and Hanawa, T. Calcification by MC3T3-E1 cells on RGD peptide immobilized on titanium through electrodeposited PEG. Biomaterials 30, 1281, 2009.
26. Roessler, S., Born, R., Scharnweber, D., Worch, H., Sewing, A., and Dard, M. Biomimetic coatings functionalized with adhesion peptides for dental implants. J Mater Sci Mater Med 12, 871, 2001.
27. Zhang, L., Hum, M., Wang, M., Li, Y., Chen, H., Chu, C., and Jiang, H. Evaluation of modifying collagen matrix with RGD peptide through periodate oxidation. J Biomed Mater Res A 73, 468, 2005.
28. Monteiro, G.A., Fernandes, A.V., Sundararaghavan, H.G., and Shreiber, D.I. Positively and negatively modulating cell adhesion to type I collagen via peptide grafting. Tissue Eng Part A 17, 1663, 2011.
29. Tuan, T.L., Cheung, D.T., Wu, L.T., Yee, A., Gabriel, S., Han, B., Morton, L., Nimni, M.E., and Hall, F.L. Engineering, expression and renaturation of targeted TGF-beta fusion proteins. Connect Tissue Res 34, 1, 1996.
30. Han, B., Hall, F.L., and Nimni, M.E. Refolding of a recombinant collagen-targeted TGFbeta2 fusion protein expressed in Escherichia coli. Protein Expr Purif 11, 169, 1997.
31. Andrades, J.A., Wu, L.T., Hall, F.L., Nimni, M.E., and Becerra, J. Engineering, expression, and renaturation of a collagen- targeted human bFGF fusion protein. Growth Factors 18, 261, 2011.
32. Gregory, C.A., Gunn, W.G., Peister, A., and Prockop, D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329, 77, 2004.
33. Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J.M., Gillespie, M.T., Martin, T.J., Suda, T., and Takahashi, N. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factorkappaB ligand. Endocrinology 142, 3656, 2001.
34. Sciadini, M.F., and Johnson, K.D. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res 18, 289, 2000.
35. Shin, H., Jo, S., and Mikos, A.G. Biomimetic materials for tissue engineering. Biomaterials 24, 4353, 2003.
36. Taubenberger, A.V., Woodruff, M.A., Bai, H., Muller, D.J., and Hutmacher, D.W. The effect of unlocking RGD-motifs in collagen I on pre-osteoblast adhesion and differentiation. Biomaterials 31, 2827, 2010.
37. Shin, H., Jo, S., and Mikos, A.G. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg- Gly-Asp peptides and a poly(ethyleneglycol) spacer. J Biomed Mater Res 61, 169, 2002.
38. Matsuki, K., Sasho, T., Nakagawa, K., Tahara, M., Sugioka, K., Ochiai, N., Ogino, S., Wada, Y., and Moriya, H. RGD peptide-induced cell death of chondrocytes and synovial cells. J Orthop Sci 13, 524, 2008.
39. Visser, R., Arrabal, P.M., Santos-Ruiz, L., Becerra, J., and Cifuentes, M. Basic fibroblast growth factor enhances the osteogenic differentiation induced by bone morphogenetic protein-6 in vitro and in vivo. Cytokine 58, 27, 2012.